论文部分内容阅读
尽管Misonidazol在临床应用上受到神经毒性的限制,但是,寻找低毒高效乏氧细胞放射增敏剂依然是肿瘤放射生物学者及药物学者感兴趣的研究课题。原因在
Although Misonidazol is limited by its neurotoxicity in clinical applications, it is still a research topic of interest to tumor radiobiologists and pharmacologists to search for radiosensitizers with low cytotoxicity and hypoxia. The reason is